Selenoproteins in Muscle Aging and Sarcopenia
Current understanding
Selenium status, delivered biologically as selenoproteins (GPX4, SELENOP, SELENOW, SELENOT, SELENON), is proposed as an upstream nutrient input into aging muscle homeostasis — limiting lipid peroxidation and ferroptosis (GPX4), resolving inflammation (SELENOP/W), and supporting protein and calcium handling and regeneration (SELENOT/N). A 2026 systematic review consolidates epidemiological, clinical, and animal evidence for a dose-responsive association between selenium deficiency and sarcopenia risk [human-observational + animal-model], but no dedicated RCT has yet tested selenium repletion for a sarcopenia endpoint, so the causal chain remains inferred rather than established in humans.
Evidence log
- 2026-09-18 — Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.: cross-connection with muscle-calcium-handling: SELENOT/SELENON are ER-resident selenoproteins implicated in Ca²⁺ handling and SR–ER homeostasis; selenium deficiency is proposed to destabilize muscle calcium regulation, connecting selenoprotein biology to age-related excitation-contraction defects. (novelty: 3)